Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 281, Issue 3 50-3, 2001, Pages

  Fryer, R M ^a   Patel, H H ^a   Hsu, A K ^a   Gross, G J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

C jun NH2 terminal kinase; Mitogen activated protein kinase; Opioid; P38; Preconditioning

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; JANUS KINASE; OPIATE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GRAVIMETRY; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

EID: 0034829970     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.281.3.h1184     Document Type: Article

References (43)

1. Cytoprotection by jun kinase during nitric oxide-induced cardiac myocyte apoptosis
2. Phosphorylation state of hsp 27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes
3. Okadaic acid and anisomycin are protective and stimulate the SAPK/JNK pathway
4. Inhibition of the cardiac p38-MAPK pathway by SB 203580 delays ischemic cell death
5. Characterization of the infarct-limiting effect of delayed preconditioning: Timecourse and dose-dependency studies in rabbit myocardium
6. Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs
7. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle
8. ATP
9. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses
10. The p38-MAPK inhibitor, SB 203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)
11. ATP channels
12. ATP channels
13. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection
14. Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in the rat heart
15. Essential activation of protein kinase C-δ in opioid-initiated cardioprotection
16. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by adenosine in the perfused rat heart
17. Oxidative stress-induced actin reorganization mediated by p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells
18. The mechanism of the tetrazolium reaction in identifying myocardial infarction
19. Hypoxia/reoxygenation stimulates jun kinase activity through redox signaling in cardiac myoctes
20. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
21. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
22. Involvement of a p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia
23. Ischemic preconditioning triggers tyrosine kinase signaling: A potential role for MAPKAP kinase 2
24. The p38 MAPK inhibitor, SB 293580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical
25. Role of p 38 MAP kinase in myocardial stress
26. S.B.203580, an inhibitor of p38 MAPK abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts
27. Increased preproenkephalin A gene expression in the rat heart after induction of a myocardial infarction
28. Role of p38 mitogen-activated protein kinases in preconditioning. A detrimental factor or a protective kinase?
29. PKC-dependent activation of p46/p 54 JNKs during ischemic preconditioning in conscious rabbits
30. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart
31. SAPKs regulation of ischemic preconditioning
32. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes
33. Inhibition of p38 MAPK a/b reduces ischemic injury and does not block protective effects of preconditioning
34. ATP channels
35. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts
36. ATP channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway
37. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p 38 mitogen activated protein kinase family
38. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart
39. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors
40. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species
41. Pyridinyl Imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site
42. MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner
43. The expression of constituitively active isotypes of protein kinase C to investigate preconditioning